Azeliragon
Azeliragon (TTP488) is a small molecule RAGE antagonist investigated for Alzheimer's disease therapy. It has been studied in vitro for receptor blockade and in clinical trials for mild-to-moderate AD, showing research utility in neuroinflammation and neurodegeneration models.
Product Specifications
CAS Number
603148-36-3
Product Name Alternative
Beta Amyloid, BetaAmyloid, advancedglycationendproducts, advanced glycation end products, Abeta, Amyloid-β, bAmyloid, Azeliragon, b Amyloid, Inhibitor, inhibit, PF04494700, PF-04494700, PF 04494700, RAGE, β Amyloid, β-amyloid peptide, βAmyloid, TTP 488, TTP488, TTP-488
Field of Research
Neuroscience
Purity
96.70% (May vary between batches)
Solubility
DMSO:11 mg/mL (20.67 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.76 mM)
Smiles
CCCCc1nc (cn1-c1ccc (Oc2ccc (Cl) cc2) cc1) -c1ccc (OCCCN (CC) CC) cc1
Molecular Formula
C32H38ClN3O2
Molecular Weight
532.12
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
